Review: Benefit Outweighs Harm of Statins for Primary Prevention of CVD

THURSDAY, July 15, 2021 -- The risk for adverse events attributable to statins is low and does not outweigh their efficacy in primary prevention of cardiovascular disease, according to a review published online July 14 in The BMJ. Ting Cai, M.P.H.,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news